Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60281 | MPO-IN-4 | ||
MPO-IN-4 (compound 12) 是一种有效的选择性髓过氧化物酶 (MPO) 抑制剂,IC50为 25 nM。MPO-IN-4对甲状腺过氧化物酶(TPO)也显示抑制作用,IC50为2.2 μM。MPO-IN-4 对甲基鸟嘌呤甲基转移酶 (MGMT) 没有影响。 | |||
T69798 |
4-Me-PDTic HCl
|
||
4-Me-PDTic is a potent and selective Kappa Opioid Receptor Antagonist. 4-Me-PDTic had a Ke = 0.37 nM in a [35S]GTPγS binding assay and was 645- and >8100-fold selective for the κ relative to the μ and δ opioid receptors, respectively. Calculated logBB and CNS (central nervous system) multiparameter optimization (MPO) and low molecular weight values all predict that 4-Me-PDTic will penetrate the brain and pharmacokinetic studies in rats shows that 4-Me-PDTic does indeed penetrate the brain. | |||
T75242 |
Bivalirudin TFA
|
||
Bivalirudin TFA 是20个氨基多肽,可逆地抑制凝血酶。 | |||
T36660 |
Olsalazine-13C6
Olsalazine-13C6 |
||
Olsalazine-13C6is intended for use as an internal standard for the quantification of olsalazine by GC- or LC-MS. Olsalazine is an orally bioavailable prodrug form of the anti-inflammatory agent 5-aminosalicylic acid that is cleaved by bacterial azo reductases in the gut to generate active 5-ASA.1In vitro, olsalazine increases ion transport in isolated rabbit distal ileum when applied to the luminal side (ED50= 0.3 mM) and stimulates fluid transport in rat jejunum when used at a concentration of ... |